A blinded, multi-center evaluation of two commercial in vitro tests for latex-specific IgE antibodies

Dennis Randall Ownby, Barbara Magera, P. Brock Williams

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Purpose: To compare the diagnostic value of two commercial in vitro tests for the detection of latex-specific IgE antibodies. Methods: Serum samples were collected from latex-allergic and nonlatex-allergic individuals. Persons were classified as latex allergic if they had a positive clinical history and a positive skin prick test with a latex extract. Persons with no latex-related symptoms and negative skin tests were classified as nonlatex allergic. The serum samples were tested in a blinded fashion by a laboratory using the CAP (Pharmacia-Upjohn) and AlaSTAT (Diagnostic Products Company) assays. Values of 0.35 k(A) U/L or greater were considered positive in both tests. Results: The 143 sera studied came from 83-latex allergic and 60 nonallergic persons. The in vitro tests were found to have sensitivities of 79.5% and 73.8%, and specificities of 90.2% and 91.7%, for CAP and AlaSTAT, respectively. The positive predictive values were 91.7% and 92.5%, while the negative predictive values were 76.4% and 71.4% for the CAP and AlaSTAT, respectively. Conclusion: In individuals classified by the combination of clinical history and skin test results, both the Pharmacia CAP and the DPC AlaSTAT demonstrated acceptable sensitivities, specificities, and predictive values for detection of antilatex IgE antibodies. These findings suggest that both assays can be useful adjuncts to the diagnosis of latex allergy.

Original languageEnglish (US)
Pages (from-to)193-196
Number of pages4
JournalAnnals of Allergy, Asthma and Immunology
Volume84
Issue number2
DOIs
StatePublished - Jan 1 2000

Fingerprint

Latex
Immunoglobulin E
Antibodies
Skin Tests
Serum
Latex Hypersensitivity
In Vitro Techniques
Sensitivity and Specificity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

A blinded, multi-center evaluation of two commercial in vitro tests for latex-specific IgE antibodies. / Ownby, Dennis Randall; Magera, Barbara; Williams, P. Brock.

In: Annals of Allergy, Asthma and Immunology, Vol. 84, No. 2, 01.01.2000, p. 193-196.

Research output: Contribution to journalArticle

@article{b68d912dd5ac483e9566c61a223fc8f9,
title = "A blinded, multi-center evaluation of two commercial in vitro tests for latex-specific IgE antibodies",
abstract = "Purpose: To compare the diagnostic value of two commercial in vitro tests for the detection of latex-specific IgE antibodies. Methods: Serum samples were collected from latex-allergic and nonlatex-allergic individuals. Persons were classified as latex allergic if they had a positive clinical history and a positive skin prick test with a latex extract. Persons with no latex-related symptoms and negative skin tests were classified as nonlatex allergic. The serum samples were tested in a blinded fashion by a laboratory using the CAP (Pharmacia-Upjohn) and AlaSTAT (Diagnostic Products Company) assays. Values of 0.35 k(A) U/L or greater were considered positive in both tests. Results: The 143 sera studied came from 83-latex allergic and 60 nonallergic persons. The in vitro tests were found to have sensitivities of 79.5{\%} and 73.8{\%}, and specificities of 90.2{\%} and 91.7{\%}, for CAP and AlaSTAT, respectively. The positive predictive values were 91.7{\%} and 92.5{\%}, while the negative predictive values were 76.4{\%} and 71.4{\%} for the CAP and AlaSTAT, respectively. Conclusion: In individuals classified by the combination of clinical history and skin test results, both the Pharmacia CAP and the DPC AlaSTAT demonstrated acceptable sensitivities, specificities, and predictive values for detection of antilatex IgE antibodies. These findings suggest that both assays can be useful adjuncts to the diagnosis of latex allergy.",
author = "Ownby, {Dennis Randall} and Barbara Magera and Williams, {P. Brock}",
year = "2000",
month = "1",
day = "1",
doi = "10.1016/S1081-1206(10)62755-X",
language = "English (US)",
volume = "84",
pages = "193--196",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "2",

}

TY - JOUR

T1 - A blinded, multi-center evaluation of two commercial in vitro tests for latex-specific IgE antibodies

AU - Ownby, Dennis Randall

AU - Magera, Barbara

AU - Williams, P. Brock

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Purpose: To compare the diagnostic value of two commercial in vitro tests for the detection of latex-specific IgE antibodies. Methods: Serum samples were collected from latex-allergic and nonlatex-allergic individuals. Persons were classified as latex allergic if they had a positive clinical history and a positive skin prick test with a latex extract. Persons with no latex-related symptoms and negative skin tests were classified as nonlatex allergic. The serum samples were tested in a blinded fashion by a laboratory using the CAP (Pharmacia-Upjohn) and AlaSTAT (Diagnostic Products Company) assays. Values of 0.35 k(A) U/L or greater were considered positive in both tests. Results: The 143 sera studied came from 83-latex allergic and 60 nonallergic persons. The in vitro tests were found to have sensitivities of 79.5% and 73.8%, and specificities of 90.2% and 91.7%, for CAP and AlaSTAT, respectively. The positive predictive values were 91.7% and 92.5%, while the negative predictive values were 76.4% and 71.4% for the CAP and AlaSTAT, respectively. Conclusion: In individuals classified by the combination of clinical history and skin test results, both the Pharmacia CAP and the DPC AlaSTAT demonstrated acceptable sensitivities, specificities, and predictive values for detection of antilatex IgE antibodies. These findings suggest that both assays can be useful adjuncts to the diagnosis of latex allergy.

AB - Purpose: To compare the diagnostic value of two commercial in vitro tests for the detection of latex-specific IgE antibodies. Methods: Serum samples were collected from latex-allergic and nonlatex-allergic individuals. Persons were classified as latex allergic if they had a positive clinical history and a positive skin prick test with a latex extract. Persons with no latex-related symptoms and negative skin tests were classified as nonlatex allergic. The serum samples were tested in a blinded fashion by a laboratory using the CAP (Pharmacia-Upjohn) and AlaSTAT (Diagnostic Products Company) assays. Values of 0.35 k(A) U/L or greater were considered positive in both tests. Results: The 143 sera studied came from 83-latex allergic and 60 nonallergic persons. The in vitro tests were found to have sensitivities of 79.5% and 73.8%, and specificities of 90.2% and 91.7%, for CAP and AlaSTAT, respectively. The positive predictive values were 91.7% and 92.5%, while the negative predictive values were 76.4% and 71.4% for the CAP and AlaSTAT, respectively. Conclusion: In individuals classified by the combination of clinical history and skin test results, both the Pharmacia CAP and the DPC AlaSTAT demonstrated acceptable sensitivities, specificities, and predictive values for detection of antilatex IgE antibodies. These findings suggest that both assays can be useful adjuncts to the diagnosis of latex allergy.

UR - http://www.scopus.com/inward/record.url?scp=0034008799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034008799&partnerID=8YFLogxK

U2 - 10.1016/S1081-1206(10)62755-X

DO - 10.1016/S1081-1206(10)62755-X

M3 - Article

VL - 84

SP - 193

EP - 196

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 2

ER -